The IMA Group Acquires Clinical Trials of America


The IMA Group today announced the completion of its purchase of Clinical Trials of America , a multi-therapeutic clinical trials organization that adds four additional independent and six embedded site locations in Louisiana and North Carolina to the IMA portfolio.
CTA, situated in Monroe, Louisiana, will continue to function with its current leadership, investigators, and staff, led by previous CEO and President Jeb Andrews, Ph.D. Terms of the transaction were not disclosed.

The deal increases scale, diversity, and further extends the reach of IMA Clinical Research in the Southeast by leveraging CTA’s strong therapeutic knowledge in cardiology, gastrointestinal, dermatology, vaccines, general medicine, and psychiatry. It also provides additional physician offices with IMA’s tech-enabled productivity solutions and central services approach. The company’s innovative research capabilities will also help accelerate startup and patient recruitment, as well as provide more patients with trial opportunities for additional disease states such as nonalcoholic steatohepatitis (NASH), hypertension, atrial fibrillation, asthma, and smoking cessation.

The transaction marks the seventh acquisition the IMA Group’s Clinical Research division has completed since 2018 and the 15th total acquisition within the company in the same period. Previous acquisitions have focused on key regional workers’ compensation IME and case management companies, as well as behavioral health and other screenings and social security disability evaluation companies. The strategic initiatives and organic growth are helping to position the company as one of the leading independent providers of outsourced healthcare evaluation and clinical research services.

As Senior Regional Director of Operations, Dr. Andrews joins the IMA Clinical Research team. Dr. Andrews, a physician assistant and public health professional by training, will continue to direct the CTA sites while also working as a sub-investigator. He will also help IMA Clinical Research with new site development and primary investigator onboarding.

For over 30 years, The IMA Group, headquartered in Tarrytown, New York and with offices nationwide, has been dedicated to helping people get back to work and productivity. Over the past 10 years, IMA has conducted more than three million evaluations nationwide, utilizing thousands of providers based both at IMA’s 150+ offices as well as independent locations. We provide Government Services clients with medical, psychological and related evaluations, as well as ancillary services.

Related Stories